Free Trial

3 Bargain Stocks Under $20 With Major Growth Potential

SAO PAULO, BRAZIL - Jul 03, 2021: Nubank brazilian fintech logo visible on smartphone screen, and website homepage on background - Stock Editorial Photography

Key Points

  • Many of the most popular stocks trade at prices out of reach for some retail investors.
  • Bargain stocks under $20 may offer growth potential without high price tags.
  • It's essential to watch for growth indicators for inexpensive stocks, as well as signs of stability more broadly.
  • 5 stocks we like better than NexGen Energy.

For retail investors, momentum and trends can be drivers of investment decisions and interest. The stocks that analysts and other investors are talking about most may hold a special appeal (although timing the market and ensuring that you buy in at an appropriate time are difficult challenges). But many of the most popular stocks—companies including Apple Inc. NASDAQ: AAPL, Amazon.com Inc. NASDAQ: AMZN, and NVIDIA Corp. NASDAQ: NVDA—trade for well over $100 per share, making them inaccessible to some investors.

Investors looking for lower-priced shares of companies with solid growth potential might consider a pool of inexpensive stocks under $20 per share. These are distinct from ultra-cheap penny stocks, often plagued by low liquidity and high volatility, but are nonetheless more affordable for many retail investors.

NU: Efficient Latin American Digital Banking Platform

Brazilian financial services company Nu Holdings Ltd. NYSE: NU is the parent of Nubank, a digital banking platform rapidly expanding throughout Latin America. It has also been a favorite of legendary investor Warren Buffett, who has flagged the company as one to watch for many investors.

NU Today

Nu Holdings Ltd. stock logo
NUNU 90-day performance
NU
$13.85
-0.02 (-0.14%)
(As of 08:59 AM ET)
52-Week Range
$6.80
$15.16
P/E Ratio
53.27
Price Target
$14.08

Nu is part of the highly competitive fintech space, and its performance over the last several years stands out among better-known firms like Block Inc. NYSE: SQ. Most of these firms soared to lofty heights in 2021 and have fallen since then. Nu shares have climbed more or less steadily in the last year, nearly doubling.

With no physical branches, Nubank is a streamlined operation that keeps expenses low. The platform's member base has recently surpassed 100 million customers and is growing at a mid-20% rate year-over-year. Notably, each new member generates profit for the company almost immediately, as it costs Nu under a dollar per user per month for service charges. Monthly average revenue per active customer as of the latest quarter was $11.20. The company has also recently expanded operations into Mexico and Colombia.

BIOX: Bargain Price for a Long-Term Growth Opportunity

Bioceres Crop Solutions Corp. NASDAQ: BIOX aims to develop products and tools to help make crops resistant to drought and climate change and to increase yields. The company has struggled in recent quarters to overcome a bear market in agricultural commodities and to drive profitability while controlling its debt load, prompting a stock decline of more than 28% in the last year.

Bioceres Crop Solutions Today

Bioceres Crop Solutions Corp. stock logo
BIOXBIOX 90-day performance
Bioceres Crop Solutions
$8.15
+0.30 (+3.82%)
(As of 07:44 AM ET)
52-Week Range
$7.74
$14.05
P/E Ratio
815.00
Price Target
$13.63

However, in mid-September, the firm released its latest quarterly report, and the data prompted several Wall Street analysts to reiterate a "buy" rating even as they lowered their price targets. Fourth-quarter revenues climbed by 18% thanks in large part to sales of genetically modified HB4 wheat. This is solid if it is below the expectations of many analysts. Sales of HB4 at lower margins did contribute to relatively flat gross profit and EBITDA.

But there is also reason for optimism: Bioceres announced changes to its approach to HB4 to a more stable, if slower, growth model. Notably, a shift in regulations in the U.S. has opened the door for increased domestic business, which could also have a seismic impact on top-and bottom-line performance. However, it will likely take time to roll out commercialization. This suggests that investors willing to stick with BIOX shares may see significant longer-term growth.

NXE: AI Power Shifts to Nuclear

NexGen Energy Today

NexGen Energy Ltd. stock logo
NXENXE 90-day performance
NexGen Energy
$6.60
-0.03 (-0.45%)
(As of 08:46 AM ET)
52-Week Range
$4.95
$8.88
Price Target
$11.00

Nuclear energy is increasingly popular among companies with significant power needs for AI and data center applications. Companies like Microsoft Corp. NASDAQ: MSFT and others have announced plans to harness nuclear power for these purposes going forward. NexGen Energy Ltd. NYSE: NXE is a leading exploration and development company focused on uranium, a key component of clean nuclear energy.

With the Fed's recent rate cut, oil could be poised for a new bull market. Other energy firms like NexGen will likely get pulled along with it. This, coupled with the secular shift toward renewable energy solutions and increasing demand for nuclear AI power, has prompted analysts to assign an average price target of $11.00 for NXE shares, nearly two-thirds higher than current levels.

Inexpensive Doesn't Always Mean Growth

Just because a company's shares are trading at a bargain relative to other firms does not necessarily mean that those stocks have outsized growth potential. In some cases, as with BIOX above, growth opportunities may be strongest over the long term.

Should you invest $1,000 in NexGen Energy right now?

Before you consider NexGen Energy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NexGen Energy wasn't on the list.

While NexGen Energy currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Nathan Reiff
About The Author

Nathan Reiff

Contributing Author

Fundamental analysis, ETFs, Consumer Staples

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Apple (AAPL)
4.4831 of 5 stars
$227.79+0.1%0.44%35.43Moderate Buy$238.76
Amazon.com (AMZN)
4.8694 of 5 stars
$187.97-1.7%0.11%52.65Buy$222.84
NVIDIA (NVDA)
4.8922 of 5 stars
$121.40-2.1%0.03%70.99Moderate Buy$142.10
NU (NU)
3.0653 of 5 stars
$13.87+0.4%12.04%53.35Moderate Buy$14.08
Block (SQ)
4.5161 of 5 stars
$66.97+0.7%N/A86.98Moderate Buy$87.34
Bioceres Crop Solutions (BIOX)
3.9648 of 5 stars
$7.85-1.5%N/A785.00Buy$13.63
Microsoft (MSFT)
4.9498 of 5 stars
$428.02-0.8%0.78%37.06Moderate Buy$493.94
NexGen Energy (NXE)
2.2683 of 5 stars
$6.63-0.5%N/A-662.34Strong Buy$11.00
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

Recent Videos

Why Congress Is Betting Big on Chubb: The Underrated Insurance Stock
AST SpaceMobile Takes Major Leap in Global Connectivity with Satellite Launch
Why Congress Is Betting Big on Broadcom in 2024

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines